ORIGENIS

origenis-logo

Origenis provides small molecule drug discovery services. It offers drug design, chemical synthesis, and biological characterization services combined with its proprietary small molecule drug discovery technology platform. Its technology platforms include MOREsystem and MolMind which provide direct exploitation of huge chemical spaces and delivers straightforward synthetic routes generating patentable drug candidates in less time.

#SimilarOrganizations #Website #More

ORIGENIS

Industry:
Biotechnology Pharmaceutical

Founded:
2005-01-01

Address:
Martinsried, Bayern, Germany

Country:
Germany

Website Url:
http://www.origenis.de

Total Employee:
11+

Status:
Active

Contact:
+498978016760

Email Addresses:
[email protected]

Technology used in webpage:
Euro OVH Envoy 3 To 9 CcTLD Redirects


Similar Organizations

fnp-clinical-logo

FNP Clinical

FNP Clinical is a contract Research Organisation offering comprehensive set of services for Phase I-IV clinical trials in Russia.

optimed-sa-logo

Optimed SA

Optimed SA is a contract research organization, provides services in clinical research.

total-scientific-logo

Total Scientific

Total Scientific is a contract research organisation that specialises in providing biomarker-related services to the pharmaceutical

viroclinics-biosciences-logo

Viroclinics Biosciences

Viroclinics Biosciences is a contract research and clinical laboratory service company providing diagnostic and preclinical studies.

zelmic-logo

Zelmic

Zelmic is a contract research organization dedicated to local delivery of small molecules, peptides and proteins

Official Site Inspections

http://www.origenis.de Semrush global rank: 5.25 M Semrush visits lastest month: 1.56 K

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Origenis"

Team | Origenis | Planegg

Prior Origenis, as Head of Molecular Modeling at Morphochem, he invented protein- and ligand-based drug design methods, QSPR, parallel evolutionary search algorithms, and multiparametric optimization techniques, that together โ€ฆSee details»

Origenis GmbH - Innovations- und Gründerzentrum โ€ฆ

Origenis was founded in October 2005 through a management buy-out by Michael Almstetter, Dr. Michael Thormann, and Dr. Andreas Treml, who decided to continue the development and โ€ฆSee details»

Origenis - Crunchbase Company Profile & Funding

Origenis is a contract research organisation offering services in drug design, synthesis, and characterisation.See details»

Origenis GmbH (DE) - Life-Sciences-Europe.com

Origenis (Group) Predecessor: Morphochem (Group) Industry: drug discovery services: Person: Almstetter, Michael (Origenis 202012 Managing Director) Person 2: Thormann, Michael โ€ฆSee details»

Biotech company Origenis welcomes Prof. Hendrik Liebers as โ€ฆ

The industry expert will play a key role in supporting the companyโ€™s strategic development. July 23, 2023Origenis is a technology platform-based biotech company located at the IZB that โ€ฆSee details»

Origenis GmbH - Innovations- und Gründerzentrum โ€ฆ

Origenis wurde im Oktober 2005 durch einen Management-Buy-out von Michael Almstetter, Dr. Michael Thormann und Dr. Andreas Treml gegründet, die sich entschlossen, die Entwicklung โ€ฆSee details»

origenis GmbH Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for origenis GmbH of Planegg, Bayern. Get the latest business insights from Dun & Bradstreet. D&B Business โ€ฆSee details»

Origenis - Products, Competitors, Financials, Employees, โ€ฆ

Origenis.de. Overview & Products; People; About Origenis. Origenis is a biotechnology company focused on the development of small molecule therapeutics. The company leverages AI โ€ฆSee details»

Origenis Company Profile - Office Locations, Competitors ... - Craft

Origenis has 5 employees at their 1 location. See insights on Origenis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Origenis Company Profile 2024: Valuation, Investors, โ€ฆ

Origenis General Information Description. Developer of small molecule kinase inhibitors for CNS disorders. The company develops a brain-penetrating highly selective small molecule medicines and diagnostics for a variety of โ€ฆSee details»

Biotech company Origenis welcomes Prof. Hendrik Liebers as โ€ฆ

As an experienced manager and expert in the biotech and pharma scene, he enriches our team with his valuable expertise and supports us in strategic implementation,โ€ said Dr. Michael โ€ฆSee details»

Biotech-Firma Origenis begrüßt Prof. Hendrik Liebers als Chairman โ€ฆ

โ€žOrigenis hat über einen Zeitraum von mehr als 15 Jahren eine Technologiesuite und Kompetenz im Bereich Medizinalchemie auf Weltklasseniveau aufgebaut. Es gibt in der europäischen โ€ฆSee details»

Origenis (und Leukocare) unter die Top10 Europäischen Drug

May 3, 2019 Mit diesem parallelen Ansatz für neue Kandidaten spart Origenis erheblich Zeit und Geld und verbessert die Erfolgswahrscheinlichkeit bei der Entdeckung von niedermolekularen โ€ฆSee details»

AI Innovation Platform | Origenis | Planegg

Our AI-driven drug design and synthesis planning engine combines soft-synthesis planning fed by >150,000 reaction rules applied to existing in-house and commercial building blocks, state-of โ€ฆSee details»

More documents for Origenis (Group) - Life-Sciences-Europe.com

BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl โ€“ the European Association of Bioindustries; BioIndustry Association (BIA) โ€ฆSee details»

origenis GmbH (origenis GmbH) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ่ฏ•้ชŒ_ๆŠ•่ž่ฅ โ€ฆ

Abstract Purpose AT04A and AT06A are two AFFITOPE® peptide vaccine candidates being developed for the treatment of hypercholesterolemia by inducing proprotein convertase โ€ฆSee details»

Careers | Origenis | Planegg

Origenis hires people with a passion to make a difference to the health of millions of people globally. top of page. Our Work. Our Vision; What we do; How we work; Where we come from; โ€ฆSee details»

Origenis featured on the cover of Pharma Tech Outlook Drug โ€ฆ

April 26, 2019 A new approach to small molecule drug discoveryA multipart AI-based, drug discovery platform, optimising compounds for specificity, efficacy, physiochemical properties, โ€ฆSee details»

Drug Pipeline | Origenis | Planegg

Our drug pipeline consists of preclinical small molecule drugs that are designed to hit select targets with high potency and outstanding selectivity in difficult-to-reach tissues of interest like โ€ฆSee details»

linkstock.net © 2022. All rights reserved